tiprankstipranks
Trending News
More News >
Pulse Biosciences (PLSE)
NASDAQ:PLSE
US Market
Advertisement

Pulse Biosciences (PLSE) Ratios

Compare
266 Followers

Pulse Biosciences Ratios

PLSE's free cash flow for Q2 2025 was $0.00. For the 2025 fiscal year, PLSE's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
12.05 6.76 10.39 4.30 2.95
Quick Ratio
12.04 6.76 10.39 3.62 2.95
Cash Ratio
11.85 6.61 10.22 3.36 1.64
Solvency Ratio
-4.26 -2.77 -0.72 -3.34 -2.64
Operating Cash Flow Ratio
-4.96 -4.93 -7.86 -6.35 -4.66
Short-Term Operating Cash Flow Coverage
-30.50 0.00 -51.27 -124.08 -65.25
Net Current Asset Value
$ 92.40M$ 30.53M$ -17.98M$ 18.07M$ 3.94M
Leverage Ratios
Debt-to-Assets Ratio
0.07 0.15 0.98 0.21 0.28
Debt-to-Equity Ratio
0.08 0.21 -33.79 0.32 0.50
Debt-to-Capital Ratio
0.07 0.17 1.03 0.24 0.33
Long-Term Debt-to-Capital Ratio
0.06 0.00 1.04 0.00 0.00
Financial Leverage Ratio
1.15 1.33 -34.64 1.52 1.80
Debt Service Coverage Ratio
-49.11 -31.06 -41.87 -56.72 -89.96
Interest Coverage Ratio
0.00 -31.95 -129.59 -97.54 0.00
Debt to Market Cap
<0.01 0.00 0.70 <0.01 <0.01
Interest Debt Per Share
0.12 0.22 2.25 0.43 0.49
Net Debt to EBITDA
1.37 0.83 -0.26 0.28 0.02
Profitability Margins
Gross Profit Margin
16.95%0.00%-1606.29%-38.79%0.00%
EBIT Margin
-3047.54%0.00%-8293.86%-4443.86%0.00%
EBITDA Margin
-4306.13%0.00%-8100.29%-4363.05%0.00%
Operating Profit Margin
-4341.05%0.00%-8293.86%-4443.86%0.00%
Pretax Profit Margin
-4088.22%0.00%-8357.86%-4489.42%0.00%
Net Profit Margin
-4088.22%0.00%-8421.86%-4454.16%0.00%
Continuous Operations Profit Margin
-2936.30%0.00%-8357.86%-4489.42%0.00%
Net Income Per EBT
100.00%100.00%100.77%99.21%99.77%
EBT Per EBIT
94.18%96.87%100.77%101.03%99.77%
Return on Assets (ROA)
-56.57%-71.36%-75.70%-116.43%-120.45%
Return on Equity (ROE)
-65.27%-95.15%2622.46%-176.97%-217.25%
Return on Capital Employed (ROCE)
-64.92%-83.08%-80.75%-137.80%-148.23%
Return on Invested Capital (ROIC)
-64.08%-81.44%-79.37%-133.19%-143.28%
Return on Tangible Assets
-58.37%-77.48%-81.28%-130.92%-143.67%
Earnings Yield
-5.84%-7.18%-62.72%-15.25%-8.97%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 23.25 0.00
Payables Turnover
0.50 0.66 7.59 0.68 0.39
Inventory Turnover
27.10 0.00 0.00 0.34 0.00
Fixed Asset Turnover
0.22 0.00 0.07 0.13 0.00
Asset Turnover
0.01 0.00 <0.01 0.03 0.00
Working Capital Turnover Ratio
0.02 0.00 0.02 0.07 0.00
Cash Conversion Cycle
-710.72 -555.21 -48.07 557.27 -942.41
Days of Sales Outstanding
0.00 0.00 0.00 15.70 0.00
Days of Inventory Outstanding
13.47 0.00 0.00 1.08K 0.00
Days of Payables Outstanding
724.19 555.21 48.07 538.60 942.41
Operating Cycle
13.47 0.00 0.00 1.10K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.66 -0.69 -1.39 -1.93 -1.52
Free Cash Flow Per Share
-0.66 -0.69 -1.40 -1.95 -1.54
CapEx Per Share
<0.01 <0.01 0.01 0.02 0.02
Free Cash Flow to Operating Cash Flow
1.01 1.00 1.01 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
-186.18 -273.07 -117.24 -123.79 -80.19
Capital Expenditure Coverage Ratio
-186.18 -273.07 -117.24 -123.79 -80.19
Operating Cash Flow Coverage Ratio
-5.40 -3.61 -0.62 -4.81 -3.11
Operating Cash Flow to Sales Ratio
-26.74 0.00 -67.16 -38.15 0.00
Free Cash Flow Yield
-3.84%-5.64%-50.44%-13.17%-6.46%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-17.48 -13.93 -1.59 -6.56 -11.15
Price-to-Sales (P/S) Ratio
714.83 0.00 134.29 292.06 0.00
Price-to-Book (P/B) Ratio
11.38 13.25 -41.81 11.60 24.23
Price-to-Free Cash Flow (P/FCF) Ratio
-26.59 -17.73 -1.98 -7.59 -15.49
Price-to-Operating Cash Flow Ratio
-26.73 -17.80 -2.00 -7.66 -15.68
Price-to-Earnings Growth (PEG) Ratio
2.16 0.28 0.07 -1.17 3.09
Price-to-Fair Value
11.38 13.25 -41.81 11.60 24.23
Enterprise Value Multiple
-15.23 -13.05 -1.92 -6.41 -11.33
Enterprise Value
1.07B 552.76M 108.82M 396.78M 553.59M
EV to EBITDA
-14.88 -13.05 -1.92 -6.41 -11.33
EV to Sales
640.92 0.00 155.45 279.82 0.00
EV to Free Cash Flow
-23.84 -16.67 -2.30 -7.28 -15.46
EV to Operating Cash Flow
-23.97 -16.73 -2.31 -7.33 -15.65
Tangible Book Value Per Share
1.50 0.83 -0.22 1.06 0.70
Shareholders’ Equity Per Share
1.55 0.92 -0.07 1.28 0.98
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 >-0.01 <0.01 <0.01
Revenue Per Share
0.02 0.00 0.02 0.05 0.00
Net Income Per Share
-1.01 -0.88 -1.74 -2.26 -2.14
Tax Burden
1.00 1.00 1.01 0.99 1.00
Interest Burden
1.34 0.97 1.01 1.01 1.00
Research & Development to Revenue
24.50 0.00 29.77 20.20 0.00
SG&A to Revenue
18.91 0.00 19.94 13.45 0.00
Stock-Based Compensation to Revenue
12.41 0.00 7.42 10.30 0.00
Income Quality
0.65 0.78 0.80 0.85 0.71
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis